1218331

AstraZeneca Pharmaceuticals LP — FEI 1825662

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 19, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mount Vernon, IN (United States)

Citations

IDCFRDescription
240121 CFR 211.194(a)(4)Complete Test Data
358321 CFR 211.110(a)Written in-process control procedures